Commercial structure

How we work

Four ways to bring us in, one named lead on every engagement, and a scope agreed in writing before it is priced.

Engagement models

Four ways to engage us

Fractional leadership

A named senior operator in your Regulatory, Quality, CMC or Clinical seat one to three days a week.

Defined-scope project

Fixed deliverable and fixed date — scoped in writing before it is priced.

Embedded team

Consultants working within your environment for the length of a programme.

Independent review

Audits, diligence and second opinions where having no stake in the outcome is the value.

Every engagement names the individual doing the work before you sign. If that person changes, you approve the replacement.

Predictable, itemised invoicing

How pricing and invoicing work

Time and materials work is invoiced monthly with detail by person, programme and task. Work trending over estimate is flagged when noticed, not when an invoice arrives. Pass-throughs are invoiced at cost, with supporting documentation attached.

What that means

Scope before price. An early warning, not a late surprise. Nothing marked up. Records structured and portable from day one.

The arc of a programme

Where you are determines what a first conversation looks like

01

Concept & feasibility

Pathway and classification analysis, product profile definition and a go/no-go recommendation.

02

Nonclinical & CMC

Phase-appropriate CMC plans, toxicology strategy, CDMO qualification and clinical supply.

03

IND / IDE & first-in-human

Submission assembly, protocol, sites, CRO and safety function before first dose.

04

Clinical development

Phase 2 and 3 delivery, risk-based oversight, data governance and agency meetings.

05

Submission, launch & lifecycle

NDA, BLA, PMA or 510(k) support through review and post-market follow-up.

Where to start